Hepatitis B virus infection in porphyria cutanea tarda
- 1 June 1986
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 6 (3) , 153-157
- https://doi.org/10.1111/j.1600-0676.1986.tb00282.x
Abstract
Serum markers of hepatitis B virus (HBV) infection were determined in 82 patients with porphyria cutanea tarda (PCT). Pathogenetic factors (alcohol, thalassemia minor, drugs) and clinical and histologic findings of PCT were taken into account. The prevalence of HBV infection was very high (70.7%). Hepatitis B surface antigen (HBsAg) was positive in 14 patients (17%). Eight patients had HBV infection as the only documented acquired factor. The clinical picture and histologic findings were aggravated by HBV infection; primary hepatic carcinoma occurred in four patients with HBV infection. Liver siderosis was histologically documented in 82.6% of cases, serum ferritin was pathologically increased in 91%, confirming the role of iron overload in PCT. A correlation (p < 0.02; chi-squared method) was found between increased serum ferritin levels and HBV infection, suggesting a possible relationship between liver siderosis and HBV clearance. HBV infection appears to be a relevant additional factor in the pathogenesis of PCT liver disease.Keywords
This publication has 20 references indexed in Scilit:
- Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferoxamine infusionLiver International, 2008
- Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusionBritish Journal of Dermatology, 1986
- Porphyria cutanea tarda in Beta-Thalassemia Trait CarriersDermatology, 1984
- Serum Ferritin as a Predictor of Host Response to Hepatitis B Virus InfectionScience, 1983
- Hepatic pathology in porphyria cutanea tardaLiver International, 1983
- High-performance liquid chromatographic differentiation of urinary free porphyrinsJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.Journal of Clinical Investigation, 1976
- Hepatitis B surface antigen and liver cell carcinomaThe Lancet Healthy Longevity, 1975